Nearly one-third of IBD patients do not undergo disease assessment before regimen change (Healio)

Nearly one-third of patients with inflammatory bowel disease did not undergo objective disease activity assessment or therapeutic drug monitoring prior to biologic dose change or discontinuation, according to a study.